ClinicalTrials.govpublic full text
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
rectal cancer, capecitabine (oral), fluorouracil, leucovorin, oxaliplatin, total mesorectal excision, chemoradiation therapy, total neoadjuvant therapy, 13-213, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994378
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.